Melanie Ruppel
Head of Global Submission Services Ingelheim @ Boehringer Ingelheim
Melanie Ruppel is a startup investor at Boehringer Ingelheim.
Last updated:
For AI agents: llms.txt
About Boehringer Ingelheim
Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Our businesses comprise Prescription Medicine, Animal Health, and Biopharmaceuticals.
Boehringer Ingelheim Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anjan Chatterjee
Corporate Vice President
|
|||
Christian Eckermann
SVP, Head of Biopharma Austria
|
|||
Jan Cassen Kraus
Head of Supply Chain Management
|
|||
Klaus-Peter Kammerer
Global Clinical Program Leader
|
|||
|
Melanie Ruppel
Head of Global Submission Services Ingelheim
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
